<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01099982</url>
  </required_header>
  <id_info>
    <org_study_id>IRB_00030622</org_study_id>
    <nct_id>NCT01099982</nct_id>
  </id_info>
  <brief_title>Assessing Changes in Myocardial Tissue and Blood in Patients With Advanced Heart Disease</brief_title>
  <official_title>Assessing Changes in Myocardial Tissue and Blood in Patients With Advanced Heart Disease, Effects of Mechanical Unloading on Myocardial Function and Structure in Humans</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Utah</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Intermountain Health Care, Inc.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>VA Salt Lake City Health Care System</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hunter Holmes McGuire VA Medical Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Utah</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hypothesis:

      Tissue and serum samples collected from end-stage heart failure patients receiving left
      ventricular assist device implantation (LVAD) or heart transplantation will provide
      information regarding the basic science of heart disease. Tissue and serum samples collected
      from a limited numbers of &quot;healthy controls&quot; (donor grafts that were not utilized for heart
      transplantation) will serve as a comparator in research database projects.

      Design:

      This is a registry project; there are no investigational treatments, drug or procedures
      associated with participation in registry activities. This project is an organized functional
      data and tissue data gathering and storing (database) endeavor with specific focus on the
      functional, structural, and molecular aspects of heart failure. Data collection will not
      immediately influence the course of treatment for any patient.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Brief description of procedures:

      After informed consent is obtained from the patient, the blood samples will be obtained
      either during a procedure from access lines inserted for the procedure or they will be drawn
      when other ordered lab work is done at specific time points during the study. Tissue samples
      will be obtained at the time of LVAD implantation by keeping the part of the left ventricular
      apex that the surgeon is removing in order to place the inflow cannula of the LVAD. No extra
      tissue sample, other than the tissue that has to be removed as a part of a standard LVAD,
      will be collected.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2008</start_date>
  <completion_date type="Anticipated">January 2022</completion_date>
  <primary_completion_date type="Anticipated">January 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in myocardial function</measure>
    <time_frame>baseline and 3 months</time_frame>
    <description>Myocardial function, measured by left ventricular ejection fraction, will be assessed pre-LVAD implant (baseline) and compared with myocardial function assessed at 3 months post-LVAD implant</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Congestive Heart Failure</condition>
  <arm_group>
    <arm_group_label>Advanced Heart Failure Therapy Group</arm_group_label>
    <description>Patients diagnosed with end stage heart failure undergoing either VAD implantation or heart transplantation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal Hearts Group</arm_group_label>
    <description>Control samples will be obtained from individuals undergoing other types of cardiac surgery during which it is routine to discard some tissue intraoperatively.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum and myocardial tissue.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Either gender, â‰¥ 13 years of age, any ethnicity, diagnosed with end stage heart failure
        undergoing either VAD implantation or heart transplantation.

        Control samples will be obtained from individuals undergoing other types of cardiac sugery
        during which it is routine to discard some tissue intraoperatively.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &gt;18 years of age diagnosed with heart failure undergoing either LVAD implantation or
             heart transplantation

          -  13 to 18 years of age, specifically, older children with heart failure whose body mass
             index is large enough to accommodate and LVAD

        Exclusion Criteria:

          -  Neither patient nor patient representative understands spoken English

          -  Neither patient nor patient's personal representative is willing to give written
             consent for participation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dean Y Li, M.D., Ph.D.</last_name>
    <role>Study Director</role>
    <affiliation>University of Utah</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Josef Stehlik, M.D., M.P.H.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Utah Health Sciences Center &amp; VA Salt Lake City Health Care System</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stavros G Drakos, M.D., Ph.D.</last_name>
    <role>Study Director</role>
    <affiliation>University of Utah</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stavros G Drakos, M.D., Ph.D.</last_name>
    <phone>801-585-2340</phone>
    <email>stavros.drakos@u2m2.utah.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Intermountain Medical Center</name>
      <address>
        <city>Murray</city>
        <state>Utah</state>
        <zip>84157</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Abdallah Kfoury, M.D.</last_name>
      <phone>801-507-7000</phone>
      <email>a.kfoury@imail.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Utah Health Sciences Center</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84132</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dean Y Li, M.D, Ph.D</last_name>
      <phone>801-585-5505</phone>
      <email>dean.li@u2m2.utah.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>VA Salt Lake City Health Care System</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84148</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Josef Stehlik, M.D, M.P.H</last_name>
      <phone>801-582-1565</phone>
      <email>josef.stehlik@hsc.utah.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hunter Holmes McGuire VA Medical Center</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23249</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gundars Katlaps, M.D.</last_name>
      <phone>804-675-5000</phone>
      <email>gundars.katlaps@va.gov</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 6, 2010</study_first_submitted>
  <study_first_submitted_qc>April 6, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 8, 2010</study_first_posted>
  <last_update_submitted>October 25, 2017</last_update_submitted>
  <last_update_submitted_qc>October 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Utah</investigator_affiliation>
    <investigator_full_name>Stavros Drakos</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Congestive Heart Failure</keyword>
  <keyword>Left Ventricular Assist Device</keyword>
  <keyword>LVAD</keyword>
  <keyword>Myocardium</keyword>
  <keyword>Remodeling</keyword>
  <keyword>Microvasculature</keyword>
  <keyword>Fibrosis</keyword>
  <keyword>Cardiac Transplant</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

